Cargando…

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease

Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously i...

Descripción completa

Detalles Bibliográficos
Autores principales: Takata, Takanobu, Sakasai-Sakai, Akiko, Ueda, Tadashi, Takeuchi, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375929/
https://www.ncbi.nlm.nih.gov/pubmed/30765817
http://dx.doi.org/10.1038/s41598-019-39202-5
_version_ 1783395449020874752
author Takata, Takanobu
Sakasai-Sakai, Akiko
Ueda, Tadashi
Takeuchi, Masayoshi
author_facet Takata, Takanobu
Sakasai-Sakai, Akiko
Ueda, Tadashi
Takeuchi, Masayoshi
author_sort Takata, Takanobu
collection PubMed
description Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously identified AGEs derived from glyceraldehyde and named them toxic AGEs (TAGE) due to their cytotoxicities and relationship with LSRD. We also reported that extracellular TAGE in the vascular system may promote CVD and that serum TAGE levels are associated with risk factors for CVD. The mechanisms responsible for the onset and/or progression of CVD by extracellular TAGE or the above risk factors involve vascular disorders. In the present study, we revealed that rat primary cultured cardiomyocytes generated intracellular TAGE, which decreased beating rates and induced cell death. LC3-II/LC3-I, a factor of autophagy, also decreased. Although intracellular TAGE may be targets of degradation as cytotoxic proteins via autophagy, they may inhibit autophagy. Furthermore, the mechanisms by which intracellular TAGE decrease beating rates and induce cell death may involve the suppression of autophagy. The present results suggest that intracellular TAGE are generated in cardiomyocytes and directly damage them, resulting in CVD.
format Online
Article
Text
id pubmed-6375929
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63759292019-02-19 Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease Takata, Takanobu Sakasai-Sakai, Akiko Ueda, Tadashi Takeuchi, Masayoshi Sci Rep Article Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously identified AGEs derived from glyceraldehyde and named them toxic AGEs (TAGE) due to their cytotoxicities and relationship with LSRD. We also reported that extracellular TAGE in the vascular system may promote CVD and that serum TAGE levels are associated with risk factors for CVD. The mechanisms responsible for the onset and/or progression of CVD by extracellular TAGE or the above risk factors involve vascular disorders. In the present study, we revealed that rat primary cultured cardiomyocytes generated intracellular TAGE, which decreased beating rates and induced cell death. LC3-II/LC3-I, a factor of autophagy, also decreased. Although intracellular TAGE may be targets of degradation as cytotoxic proteins via autophagy, they may inhibit autophagy. Furthermore, the mechanisms by which intracellular TAGE decrease beating rates and induce cell death may involve the suppression of autophagy. The present results suggest that intracellular TAGE are generated in cardiomyocytes and directly damage them, resulting in CVD. Nature Publishing Group UK 2019-02-14 /pmc/articles/PMC6375929/ /pubmed/30765817 http://dx.doi.org/10.1038/s41598-019-39202-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Takata, Takanobu
Sakasai-Sakai, Akiko
Ueda, Tadashi
Takeuchi, Masayoshi
Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
title Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
title_full Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
title_fullStr Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
title_full_unstemmed Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
title_short Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
title_sort intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375929/
https://www.ncbi.nlm.nih.gov/pubmed/30765817
http://dx.doi.org/10.1038/s41598-019-39202-5
work_keys_str_mv AT takatatakanobu intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease
AT sakasaisakaiakiko intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease
AT uedatadashi intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease
AT takeuchimasayoshi intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease